Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Carlos Besses(Hospital Del Mar), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eduardo Arellano‐Rodrigo(Vall d'Hebron Hospital Universitari), L Hernández-Nieto(Hospital Universitario de Canarias), Vicente Vicente(Centro Regional de Hemodonación), Carlos Salvador(Hospital Universitario Miguel Servet), Virginia Pérez-Andreu(Hospital General Universitario Morales Meseguer), Beatríz Bellosillo(Universitat Pompeu Fabra), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Ana Muntañola(University Hospital Mútua de Terrassa), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Arturo Pereira, Carmen Burgaleta(Universidad de Alcalá), R Ayats(Hospital de Sant Pau)
Cited by 233
Related Papers
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
|Proceedings of the National Academy of Sciences|2013|519
Platelet receptors and signaling in the dynamics of thrombus formation
|Haematologica|2009|409
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366